Reni Benjamin

Managing Director, Senior Equity Research Analyst

Dr. Benjamin joins Burrill from Rodman & Renshaw, where he served as a Managing Director and Senior Biotechnology Analyst since 2003. He has expertise in small- and mid-cap companies in the oncology and stem cell sectors and has previously been ranked among the top analyst by StarMine for recommendation performance and earnings estimate accuracy.

Prior to that, he served as an associate analyst in Needham & Company’s biotechnology equity research department. He earned a Ph.D. in biochemistry and molecular genetics at the University of Alabama at Birmingham and a B.S. in biology from Allegheny College.